Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 1/20 | 0.68 |
| ▸ | HTR3A | P46098 | 1/20 | 0.54 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.54 |
| ▸ | ACHE | P22303 | 6/20 | 0.47 |
| ▸ | BCHE | P06276 | 4/20 | 0.47 |
| ▸ | GRIN1 | Q05586 | 4/20 | 0.47 |
| ▸ | GRIN2A | Q12879 | 4/20 | 0.47 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.47 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.44 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.44 |
| ▸ | PIK3CG | P48736 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21500731 | 1.00 | HTT (0.68) | HTTHTR3AHRH4ACHEBCHE | |
| SCHEMBL3314521 | 0.84 | NR4A2 (0.53) | HTTHTR3AHRH4ACHEBCHE | |
| SCHEMBL3335843 | 0.84 | HSP90AB1 (0.57) | HTR3AHRH4HSP90AB1PIK3CG | |
| SCHEMBL29623910 | 0.81 | HTT (1.00) | HTTACHEBCHEGRIN1GRIN2A | |
| SCHEMBL29663483 | 0.81 | HTT (0.64) | HTTACHEBCHEGRIN1GRIN2A | |
| SCHEMBL8900878 | 0.81 | HTT (0.64) | HTTACHEBCHEGRIN1GRIN2A | |
| SCHEMBL30376225 | 0.81 | HTT (0.64) | HTTHTR3AHRH4ALDH1A1 | |
| SCHEMBL21500701 | 0.81 | HTT (0.64) | HTTHTR3AHRH4ALDH1A1 | |
| SCHEMBL8897424 | 0.81 | HTT (1.00) | HTTACHEBCHEGRIN1GRIN2A | |
| SCHEMBL3778992 | 0.81 | HTT (0.64) | HTTHTR3AHRH4ACHEBCHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240008488-A1 | HETEROCYCLIC COMPOUND AND HARMFUL ARTHROPOD-CONTROLLING COMPOSITION INCLUDING SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2024-01-11 | — | — | US | disclosed |
| EP-4223755-A1 | HETEROCYCLIC COMPOUND AND HARMFUL ARTHROPOD-CONTROLLING COMPOSITION INCLUDING SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-08-09 | — | — | EP | disclosed |
| CN-116456817-A | Heterocyclic compound and harmful arthropod control composition containing same | 住友化学株式会社 | 2023-07-18 | — | — | CN | disclosed |
| WO-2022071428-A1 | HETEROCYCLIC COMPOUND AND HARMFUL ARTHROPOD-CONTROLLING COMPOSITION INCLUDING SAME | 住友化学株式会社 | 2022-04-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240008488-A1 | HETEROCYCLIC COMPOUND AND HARMFUL ARTHROPOD-CONTROLLING COMPOSITION INCLUDING SAME | C5, C1QBP, C3AR1 | HTT 3632/4885HTR3A 844/4885HRH4 753/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.